Press Pharmather Announces Exclusive License Agreement with the University of Arizona for the Commercialization of Ketamine in the Treatment of Parkinson’s Disease Oct 15 • 6 min read Pharmather Inc. announced that the company has entered into an agreement with the University of Arizona for the development and commercialization of ketamine in the treatment of Parkinson’s disease.